Some CARD11 mutations carry out indeed promote ibrutinib resistance in ABC cell lines (34), and potentially also in a few DLBCL tumors treated with ibrutinib … Continue reading Some CARD11 mutations carry out indeed promote ibrutinib resistance in ABC cell lines (34), and potentially also in a few DLBCL tumors treated with ibrutinib (41, 130, 133C135)
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed